Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$10.13 - $14.6 $253 - $365
-25 Reduced 12.82%
170 $2,000
Q1 2024

May 14, 2024

SELL
$12.35 - $19.33 $1,432 - $2,242
-116 Reduced 37.3%
195 $2,000
Q4 2023

Feb 14, 2024

SELL
$12.87 - $19.09 $1,081 - $1,603
-84 Reduced 21.27%
311 $5,000
Q3 2023

Oct 31, 2023

SELL
$15.0 - $22.17 $1,485 - $2,194
-99 Reduced 20.04%
395 $5,000
Q2 2023

Aug 14, 2023

SELL
$21.6 - $30.69 $5,032 - $7,150
-233 Reduced 32.05%
494 $10,000
Q1 2023

May 09, 2023

SELL
$23.07 - $32.77 $1,522 - $2,162
-66 Reduced 8.32%
727 $20,000
Q4 2022

Feb 10, 2023

SELL
$25.29 - $35.48 $1,087 - $1,525
-43 Reduced 5.14%
793 $20,000
Q3 2022

Nov 14, 2022

SELL
$24.0 - $33.42 $1,008 - $1,403
-42 Reduced 4.78%
836 $24,000
Q2 2022

Aug 15, 2022

BUY
$24.78 - $33.36 $21,756 - $29,290
878 New
878 $22,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.12B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Guardian Wealth Management, Inc. Portfolio

Follow Guardian Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Guardian Wealth Management, Inc. with notifications on news.